Viewing Study NCT00073957


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2025-12-25 @ 4:42 PM
Study NCT ID: NCT00073957
Status: COMPLETED
Last Update Posted: 2018-01-23
First Post: 2003-12-10
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Sponsor: Beth Israel Deaconess Medical Center
Organization: